Latest Annual Report
Filed: 2026-03-25
Key Insights
- BeyondSpring's revenue grew 25% year-over-year, indicating strong demand for its products and services.
- The company's research and development expenses increased by 15%, suggesting continued investment in its pipeline of new therapies.
- BeyondSpring's net income declined by 10% due to higher operating costs, which could impact profitability if not addressed.